Glaucus Proteomics BV

Glaucus Proteomics BV Develops Next-Generation Antibody and Protein Array Technologies to Accelerate and Optimize Drug Development and Disease Management. The company was founded in 2000 and is headquartered in Utrecht, Netherlands.